400 related articles for article (PubMed ID: 8663884)
1. Bone marrow transplantation for sickle cell disease.
Walters MC; Patience M; Leisenring W; Eckman JR; Scott JP; Mentzer WC; Davies SC; Ohene-Frempong K; Bernaudin F; Matthews DC; Storb R; Sullivan KM
N Engl J Med; 1996 Aug; 335(6):369-76. PubMed ID: 8663884
[TBL] [Abstract][Full Text] [Related]
2. Collaborative multicenter investigation of marrow transplantation for sickle cell disease: current results and future directions.
Walters MC; Patience M; Leisenring W; Rogers ZR; Dinndorf P; Davies SC; Roberts IA; Yeager A; Kurtzberg J; Bunin N; Scott JP; Wall DA; Wayne AS; Wiley J; Darbyshire PJ; Mentzer WC; Smith FO; Sullivan KM
Biol Blood Marrow Transplant; 1997 Dec; 3(6):310-5. PubMed ID: 9502298
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation for sickle cell disease. The United States experience.
Johnson FL; Mentzer WC; Kalinyak KA; Sullivan KM; Abboud MR
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):22-6. PubMed ID: 8311168
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation (BMT) in 14 children with severe sickle cell disease (SCD): the French experience. GEGMO.
Bernaudin F; Souillet G; Vannier JP; Plouvier E; Lemerle S; Michel G; Bordigoni P; Lutz P; Kuentz M
Bone Marrow Transplant; 1993; 12 Suppl 1():118-21. PubMed ID: 8374551
[TBL] [Abstract][Full Text] [Related]
5. [Haploidentical hematopoietic stem cell transplantation for beta-thalassemia major in children].
Hao WG; Sun X; Liu S; Zhao Z; Chen ZX
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):546-8. PubMed ID: 19650987
[TBL] [Abstract][Full Text] [Related]
6. Stem cell transplantation for sickle cell disease: can we reduce the toxicity?
Fixler J; Vichinsky E; Walters MC
Pediatr Pathol Mol Med; 2001; 20(1):73-86. PubMed ID: 12673845
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease.
Adamkiewicz TV; Mehta PS; Boyer MW; Kedar A; Olson TA; Olson E; Chiang KY; Maurer D; Mogul MJ; Wingard JR; Yeager AM
Bone Marrow Transplant; 2004 Sep; 34(5):405-11. PubMed ID: 15247929
[TBL] [Abstract][Full Text] [Related]
8. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium.
Vermylen C; Cornu G; Ferster A; Brichard B; Ninane J; Ferrant A; Zenebergh A; Maes P; Dhooge C; Benoit Y; Beguin Y; Dresse MF; Sariban E
Bone Marrow Transplant; 1998 Jul; 22(1):1-6. PubMed ID: 9678788
[TBL] [Abstract][Full Text] [Related]
9. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E
N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319
[TBL] [Abstract][Full Text] [Related]
11. Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.
Ball LM; Lankester AC; Giordano PC; van Weel MH; Harteveld CL; Bredius RG; Smiers FJ; Egeler RM; Vossen JM
Bone Marrow Transplant; 2003 Jun; 31(12):1081-7. PubMed ID: 12796787
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
Horwitz ME; Barrett AJ; Brown MR; Carter CS; Childs R; Gallin JI; Holland SM; Linton GF; Miller JA; Leitman SF; Read EJ; Malech HL
N Engl J Med; 2001 Mar; 344(12):881-8. PubMed ID: 11259721
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin.
Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG
Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944
[TBL] [Abstract][Full Text] [Related]
15. Marrow transplantation in patients with advanced thalassemia.
Lucarelli G; Galimberti M; Polchi P; Giardini C; Politi P; Baronciani D; Angelucci E; Manenti F; Delfini C; Aureli G
N Engl J Med; 1987 Apr; 316(17):1050-5. PubMed ID: 3550463
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell transplantation for beta-thalassemia major: experience in south of Iran.
Ramzi M; Nourani H; Zakernia M; Hamidian Jahromi AR
Transplant Proc; 2004 Oct; 36(8):2509-10. PubMed ID: 15561298
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-mobilized allogeneic peripheral blood stem cell transplants in children result in rapid engraftment and a high incidence of chronic GVHD.
Levine JE; Wiley J; Kletzel M; Yanik G; Hutchinson RJ; Koehler M; Neudorf S
Bone Marrow Transplant; 2000 Jan; 25(1):13-8. PubMed ID: 10654008
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
